Skip to main content
Breaking
City Council Approves New Downtown Development ProjectSevere Thunderstorm Warning Issued for Dallas-Fort Worth AreaCity Council Approves New Downtown Development ProjectSevere Thunderstorm Warning Issued for Dallas-Fort Worth Area

This Plano Biotech Firm Raised $30 Million to Advance Duchenne Cardiomyopathy Treatment

Layten Praytor 11h agoDM
This Plano Biotech Firm Raised $30 Million to Advance Duchenne Cardiomyopathy Treatment
D Magazine

Plano biotech firm Secretome Therapeutics developing treatments for Duchenne muscular dystrophy and rare cardiomyopathies has secured major funding to advance its research and development. The company closed its $30 million Series A led by RA Capital Management this past month. The funding will support the advancement of STM-01, Secretome’s lead therapeutic candidate for Duchenne-associated cardiomyopathy. … Continued The post This Plano Biotech Firm Raised $30 Million to Advance Duchenne Cardiomyopathy Treatment appeared first on D Magazine.

This article was originally published by D Magazine. Read the full story at the source below.

Read the Full Story

This story was originally published by D Magazine.

Read at D Magazine